ARCHIVES

Genetronics Phase II Trials For Head & Neck Completed.

This article is from The Cancer Letter archive.

Vol. 27 No. 18 | May 4, 2001

Download PDF Visit The Full Archive

Related Articles

Letters to the Editor: Burzynski: Reviewers Sought To Discredit Antineoplaston Therapy

October 30, 1998

DCPC Board Oks Concept For Three New Grant Programs, Three Contracts

May 22, 1987

Professional Fundraiser Poses Eight Questions For SU2C 3.

September 19, 2008

In Brief: Cancer Control Needs More Oncologists, DCT recruiting for Prestigious Combines Job

November 21, 1975

Amgen Agrees To Buy Immunex For $16 Billion In Stock And Cash.

January 25, 2002

Tamoxifen Trial may EB Funded In Part With CCOP Money

March 22, 1991